BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30045008)

  • 21. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
    Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
    Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
    Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
    Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, colposcopic and pathological characteristics of cervical and vaginal high-grade lesions negative for HPV by Hybrid Capture 2.
    del Pino M; Rodriguez-Carunchio L; Alonso I; Torné A; Rodriguez A; Fusté P; Castillo P; Nonell R; Abu-Lhiga N; Ordi J
    Gynecol Oncol; 2011 Sep; 122(3):515-20. PubMed ID: 21632098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased incidence of atypical Papanicolaou tests from ThinPreps of postmenopausal women receiving hormone replacement therapy.
    Menezes GA; Wakely PE; Stripe DM; Nuovo GJ
    Cancer; 2001 Dec; 93(6):357-63. PubMed ID: 11748575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
    Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
    Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of combining HPV-DNA testing with follow-up Papanicolaou smear in patients with prior atypical squamous cells of undetermined significance.
    Farag R; Redline R; Abdul-Karim FW
    Acta Cytol; 2008; 52(3):294-6. PubMed ID: 18540292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study.
    Gravitt PE; Schiffman M; Solomon D; Wheeler CM; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1248-54. PubMed ID: 18483347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients.
    Patton AL; Duncan L; Bloom L; Phaneuf G; Zafar N
    Cancer; 2008 Dec; 114(6):481-8. PubMed ID: 18980288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem.
    Abati A; Jaffurs W; Wilder AM
    Cancer; 1998 Aug; 84(4):218-25. PubMed ID: 9723596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of cytologic screening results of the cervix.
    Yalti S; Gürbüz B; Bilgiç R; Cakar Y; Eren S
    Int J Gynecol Cancer; 2005; 15(2):292-4. PubMed ID: 15823114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
    Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology.
    Origoni M; Carminati G; Rolla S; Clementi M; Sideri M; Sandri MT; Candiani M
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2401-6. PubMed ID: 22382821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASCUS on cervical cytologic smears. Clinical significance.
    Yang M; Zachariah S
    J Reprod Med; 1997 Jun; 42(6):329-31. PubMed ID: 9219118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M; Zhao C
    J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A weakly positive human papillomavirus Hybrid Capture II result correlates with a significantly lower risk of cervical intraepithelial neoplasia 2,3 after atypical squamous cells of undetermined significance cytology.
    Jarboe EA; Venkat P; Hirsch MS; Cibas ES; Crum CP; Garner EI
    J Low Genit Tract Dis; 2010 Jul; 14(3):174-8. PubMed ID: 20592551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Alexander C; White M; Maleki Z; Rodriguez EF
    Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.